Synthetic peptide within human PD1 aa 24 - 170 (Extracellular).
Conjugation:
Unconjugated
PD-1 blockade works during the effector phase to restore the immune function of T cells in the periphery that have been turned off following extended or high levels of antigen exposure, as in advanced cancer. The ligands for PD-1 can be expressed by tumo